Minerva Neurosciences (NASDAQ:NERV) reported quarterly losses of $(0.64) per share which missed the analyst consensus estimate of $(0.30) by 113.33 percent. This is a 14.29 percent decrease over losses of $(0.56) per share from the same period last year.